City of Hope Medical Center: Carcinoma, Non-Small-Cell Lung trials

The registry lists 23 Carcinoma, Non-Small-Cell Lung studies with City of Hope Medical Center as lead sponsor. 8 are open to participants now and 3 have results posted.

Phase 1 9Phase 2 9Phase 3 1No phase 5(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• A PET Imaging Agent (64Cu-DOTA-Pembrolizumab) for Determining Treatment Response Among Patients With Stage IV Non-small Cell Lung Cancer Receiving PembrolizumabRecruitingNCT07619599Phase 1
• Immunotherapy Biomarkers to Predict First-line PD(L)1-based Immunotherapy Response and Selection of Second-line Treatment in Stage IIIB-IV Non-small Cell Lung Cancer, IMMUNO-BIOMAP TrialRecruitingNCT07288034Phase 2
• Photon Craniospinal Irradiation for the Treatment of Leptomeningeal Disease Secondary to Breast Cancer or Non-small Cell Lung CancerRecruitingNCT06910761Phase 2
• Carfilzomib in Combination With Sotorasib for the Treatment of Patients With KRAS G12C Mutated Advanced or Metastatic Non-small Cell Lung CancerRecruitingNCT06249282Phase 1
• Evaluation of Geriatric Assessment and Management for Older Adults With Non-small Cell Lung Cancer Receiving Chemotherapy Radiation TherapyRecruitingNCT06139627Not applicable
• Positron Emission Tomography (PET) Guided Stereotactic Body Radiation Therapy for the Treatment of Oligoprogressive Non-small Cell Lung Cancer, Melanoma, and Renal Cell CarcinomaRecruitingNCT05830058Phase 2
• Phase II Trial of Lung ChemoemobolizationRecruitingNCT05672108Phase 2
• AOH1996 for the Treatment of Refractory Solid TumorsRecruitingNCT05227326Phase 1
• Vinorelbine in Treating Patients With Advanced Solid Tumors That Have Not Responded to Treatment and Liver DysfunctionCompletedNCT00540982Phase 1/2Results posted
• Surgery, Gemcitabine, Cisplatin, and Radiation Therapy in Treating Patients With Stage II or Stage III Non-Small Cell Lung CancerTerminatedNCT00530634Phase 2Results posted
• Erlotinib Hydrochloride With or Without Celecoxib in Treating Patients With Stage IIIB-IV Non-Small Cell Lung CancerCompletedNCT00499655Phase 2Results posted
• Biologically Guided Radiation Therapy (BgRT) and Stereotactic Body Radiation Therapy (SBRT) to Tyrosine Kinase Inhibitor in Oligoprogressive Oncogenic Positive Non-Small Cell Lung CarcinomaSuspendedNCT06014827Phase 2
• Cemiplimab for the Treatment of Untreated Brain Metastases From PD-L1 >= 50% Non-Small Cell Lung CancerWithdrawnNCT05840770Phase 2
• Self-Management Survivorship Care in Stage I-III Non-small Cell Lung Cancer or Colorectal CancerActive, not recruitingNCT04428905Phase 3
• Brigatinib and Bevacizumab for the Treatment of ALK-Rearranged Locally Advanced, Metastatic, or Recurrent NSCLCActive, not recruitingNCT04227028Phase 1
• Physical Activity Intervention Before and After Surgery in Older Adults With Lung Cancer and Their Family CaregiversWithdrawnNCT04085081Not applicable
• Vaccine Therapy and Pembrolizumab in Treating Patients With Solid Tumors That Have Failed Prior TherapyActive, not recruitingNCT02432963Phase 1
• Palliative Care Intervention in Improving Symptom Control and Quality of Life in Patients With Stage II-IV Non-small Cell Lung Cancer and Their Family CaregiversCompletedNCT02243748Not applicable
• Survivorship Care Planning in Patients With Colorectal or Non-Small Cell Lung CancerCompletedNCT01741636Not applicable
• PI3K Inhibitor BKM120, Carboplatin, and Pemetrexed Disodium in Treating Patients With Stage IV Non-Small Cell Lung CancerCompletedNCT01723800Phase 1
• Fludeoxyglucose F 18 PET/CT Scans in Predicting Therapy Response in Patients With Stage IIIA Non-Small Cell Lung Cancer Undergoing ChemoradiationWithdrawnNCT01314677Not applicable
• Beta-Glucan in Treating Patients With Locally Advanced or Metastatic Non-Small Cell Lung CancerCompletedNCT00857025Phase 1
• Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Stage I-IIIB Non-Small Cell Lung Cancer After Completion of Radiation Therapy Alone or Combined Radiation Therapy and ChemotherapyCompletedNCT00738452Phase 1